Fierce BioTech

SEPTEMBER 19, 2024

In this webinar, Dr. Madeline Naylor, VP of Health Informatics RWD at Norstella, and Patrick Winniewicz, Executive Director of Healthcare Analytics Solutions at Quest Diagnostics, will discuss how today’s robust lab data sources can help improve patient access and time to treatment—and, ultimately, lead to better patient outcomes.

Treatment 52

Treatment Pharma Companies Disease 52

H1 Blog

MAY 11, 2023

Omnichannel engagement for physician marketing is a powerful tool for biotechnology and pharma companies looking to increase reach and drive engagement among HCPs. By taking a tailored approach, pharma companies can ensure they’re offering meaningful information that resonates with each individual HCP.

Pharma Companies 52

Pharma Companies Marketing Treatment Pharmaceuticals 52

Fierce BioTech

JULY 12, 2023

Real world use cases of how pharma companies are streamlining their reader workflows for accelerated AI development Logos Attribution 0 Attribution 0 Primary Category Biotech On Demand Off Enable Automatic On Demand On Registration Login Link Already registered?

Pharma Companies 52

Pharma Companies Science Research 52

Elrig

APRIL 29, 2024

Webinar | Ai At The Frontier: Empowering Early Career Professionals In Drug Discovery WEBINAR – ARE YOU CURIOUS ABOUT THE CUTTING-EDGE INTERSECTION OF ARTIFICIAL INTELLIGENCE AND DRUG DISCOVERY? big pharma or startups/spin off? thanks Big pharma experienced is very well respected within biotech or small-startups.

Bioinformatics 59

Bioinformatics Drugs Molecular Biology Cell Based Assays 59

The Pharma Data

NOVEMBER 27, 2020

This week, another pharma company revealed a new technology device that can detect if a patient is infectious or not, while the Russian government published results of its Sputnik V vaccine, claiming it is more than 95 per cent efficient 42 days after the first dose. Save your seat at IDBS’s upcoming webinar. Source link.

Vaccine 52

Vaccine Virus International Immune Response 52

Advarra

JULY 19, 2022

Advarra experts Sharon Ayd and Leslie Paul answer questions from their webinar, The IND Journey Phase I – Navigating Success. The sponsor-initiated IND is conducted by a pharma company seeking commercial approval. A: Yes, the EUA is just temporary.

Packaging 52

Packaging FDA Trials Regulations 52